Apellis Pharmaceuticals (APLS) Financial Statements

Price: $18.2
Market Cap: $2.28B
Avg Volume: 1.96M
Country: US
Industry: Biotechnology
Sector: Healthcare
Beta: 0.844
52W Range: $17.485-50.98
Website: Apellis Pharmaceuticals

Overview of Financial Statements

Financial statements are records that provide an overview of a company's financial performance and position. There are three main types of financial statements:

  • Income Statement: Shows the company's revenue, expenses, and profit over a specific period.
  • Balance Sheet: Provides a snapshot of the company's assets, liabilities, and equity at a specific point in time.
  • Cash Flow Statement: Details the cash inflows and outflows from operating, investing, and financing activities over a period.

This page presents both annual and quarterly data for these financial statements. The charts below provide a visual representation of the key metrics from each statement, helping you to quickly understand the financial health of Apellis Pharmaceuticals.


Income Statement

Revenue
Cost of Revenue
Revenue and Costs$800.00M$800.00M$600.00M$600.00M$400.00M$400.00M$200.00M$200.00M$0.00$0.0020162016201720172018201820192019202020202021202120222022202320232024202420252025
Operating Expenses
Operating Income
Operating Expenses & Income$1.20B$1.20B$800.00M$800.00M$400.00M$400.00M$0.00$0.00-$400.00M-$400.00M-$800.00M-$800.00M20162016201720172018201820192019202020202021202120222022202320232024202420252025
Breakdown December 31, 2024 December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020 December 31, 2019 December 31, 2018 December 31, 2017 December 31, 2016 December 31, 2015
Revenue $709.95M $396.59M $75.42M $66.56M $250.65M $- $- $- $- $-
Cost of Revenue $117.72M $58.51M $5.64M $5.20M $25.05M $288.02M $127.92M $50.77M $- $-
Gross Profit $592.23M $338.08M $69.79M $61.36M $225.60M $-288.02M $-127.92M $-50.77M $- $-
Gross Profit Ratio 83.42% 85.25% 92.53% 92.19% 90.01% - - - 0.00% 0.00%
Research and Development Expenses $327.57M $354.39M $387.24M $420.87M $299.92M $220.97M $105.29M $40.30M $22.98M $13.73M
General and Administrative Expenses $- $500.81M $277.16M $176.77M $139.40M $67.05M $22.64M $10.46M $4.30M $6.36M
Selling and Marketing Expenses $- $- $- $- $- $- $- $- $- $-
Selling General and Administrative Expenses $501.05M $500.81M $277.16M $176.77M $139.40M $67.05M $22.64M $10.46M $4.30M $6.36M
Other Expenses $- $- $-288.00K $1.36M $-501.00K $-175.31K $-110.76K $11.54K $157.71K $6.28K
Operating Expenses $828.62M $855.20M $664.40M $597.64M $439.32M $288.02M $127.92M $50.77M $27.28M $20.09M
Cost and Expenses $946.35M $913.71M $670.03M $602.84M $464.37M $288.02M $127.92M $50.77M $27.28M $20.09M
Interest Income $12.77M $20.93M $8.91M $418.00K $4.16M $5.11M $2.96M $- $- $-
Interest Expense $40.39M $29.58M $32.63M $13.24M $29.94M $5.28M $2.51M $96.92K $- $-
Depreciation and Amortization $1.80M $1.70M $1.49M $1.49M $859.00K $595.45K $127.92M $11.94K $27.28M $52.97M
EBITDA $-236.39M $-495.21M $-617.39M $-731.27M $-312.23M $-298.83M $- $-50.90M $157.71K $6.40M
EBITDA Ratio -33.30% -124.87% -818.58% -1098.61% -124.57% - 0.00% - - -
Operating Income $-236.39M $-517.12M $-594.61M $-536.28M $-213.73M $-288.02M $-127.92M $-50.77M $-27.28M $-46.57M
Operating Income Ratio -33.30% -130.39% -788.38% -805.67% -85.27% - - - - -
Total Other Income Expenses Net $39.68M $-9.38M $-56.89M $-209.72M $-129.30M $-16.69M $422.81K $-239.06K $157.71K $57.14K
Income Before Tax $-196.72M $-526.50M $-651.50M $-746.00M $-343.03M $-304.71M $-127.50M $-51.01M $-27.12M $-46.52M
Income Before Tax Ratio -27.71% -132.76% -863.81% -1120.75% -136.86% - - - - -
Income Tax Expense $1.16M $2.13M $669.00K $352.00K $1.84M $5.11M $-533.32K $250.61K $-27.28M $-26.54M
Net Income $-197.88M $-528.63M $-652.17M $-746.35M $-344.87M $-309.82M $-127.50M $-51.01M $-27.12M $-46.52M
Net Income Ratio -27.87% -133.29% -864.70% -1121.27% -137.59% - - - - -
EPS $-1.60 $-4.45 $-6.15 $-8.84 $-4.59 $-4.98 $-2.34 $-3.68 $-1.50 $-2.57
EPS Diluted $-1.60 $-4.45 $-6.15 $-8.84 $-4.59 $-4.98 $-2.34 $-3.68 $-1.50 $-2.57
Weighted Average Shares Outstanding 123.90M 118.68M 106.11M 84.42M 75.16M 62.23M 54.40M 13.87M 18.09M 18.09M
Weighted Average Shares Outstanding Diluted 123.90M 118.68M 106.11M 84.42M 75.16M 62.23M 54.40M 13.87M 18.09M 18.09M
SEC Filing Source Source Source Source Source Source Source Source Source Source

Balance Sheet

Total Assets
Total Liabilities
Total Assets and Liabilities$1.00B$1.00B$800.00M$800.00M$600.00M$600.00M$400.00M$400.00M$200.00M$200.00M$0.00$0.0020162016201720172018201820192019202020202021202120222022202320232024202420252025
Equity$240.00M$240.00M$180.00M$180.00M$120.00M$120.00M$60.00M$60.00M$0.00$0.0020162016201720172018201820192019202020202021202120222022202320232024202420252025
Breakdown December 31, 2024 December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020 December 31, 2019 December 31, 2018 December 31, 2017 December 31, 2016 December 31, 2015
Cash and Cash Equivalents $411.29M $351.19M $551.80M $640.19M $565.78M $351.99M $176.27M $175.64M $24.86M $36.00M
Short Term Investments $- $1.11M $6.50M $60.36M $311.87M $- $- $- $- $-
Cash and Short Term Investments $411.29M $352.30M $551.80M $700.55M $877.65M $351.99M $176.27M $175.64M $24.86M $36.00M
Net Receivables $264.93M $206.44M $7.73M $10.10M $25.00M $- $- $- $- $-
Inventory $81.40M $146.36M $85.71M $16.29M $1 $- $- $- $- $-
Other Current Assets $31.33M $61.23M $73.01M $97.11M $14.54M $21.11M $26.17M $6.37M $2.51M $2.04M
Total Current Assets $788.95M $766.33M $719.52M $824.05M $917.19M $373.09M $202.44M $182.02M $27.37M $38.04M
Property Plant Equipment Net $19.04M $21.09M $24.89M $26.08M $24.52M $15.77M $977.92K $- $- $-
Goodwill $- $- $- $- $- $- $- $- $- $-
Intangible Assets $- $- $- $- $- $- $- $- $- $-
Goodwill and Intangible Assets $- $- $- $- $- $- $- $- $- $-
Long Term Investments $- $3.24M $- $- $- $- $- $- $- $-
Tax Assets $- $- $- $- $- $- $- $- $- $-
Other Non-Current Assets $77.06M $-1.93M $15.80M $31.64M $18.86M $385.09K $116.42K $116.15K $64.53K $133.27K
Total Non-Current Assets $96.10M $22.40M $40.69M $57.72M $43.38M $16.15M $1.09M $116.15K $64.53K $133.27K
Other Assets $- $- $- $- $- $- $- $- $- $-
Total Assets $885.05M $788.73M $760.22M $881.76M $960.57M $389.24M $203.53M $182.13M $27.43M $38.18M
Account Payables $38.57M $37.52M $37.34M $16.91M $8.48M $8.36M $10.25M $3.66M $2.55M $2.48M
Short Term Debt $13.51M $6.44M $5.62M $4.12M $3.69M $5.22M $1.67M $- $- $-
Tax Payables $- $- $- $- $- $- $- $- $- $-
Deferred Revenue $- $- $- $103.24M $111.94M $- $- $- $- $-
Other Current Liabilities $133.43M $203.64M $124.64M $110.82M $116.17M $52.17M $5.10M $2.89M $1.09M $722.73K
Total Current Liabilities $185.51M $247.59M $167.61M $131.85M $128.33M $65.75M $17.02M $6.55M $3.64M $3.20M
Long Term Debt $463.03M $104.49M $107.09M $206.10M $374.05M $154.42M $25.38M $26.39M $- $-
Deferred Revenue Non-Current $- $- $- $- $- $- $- $- $- $-
Deferred Tax Liabilities Non-Current $- $- $- $- $- $- $- $- $- $-
Other Non-Current Liabilities $7.97M $242.13M $315.65M $345.15M $253.64M $134.84M $158.78K $244.29K $- $-
Total Non-Current Liabilities $471.00M $346.62M $422.74M $551.26M $627.68M $289.26M $25.54M $26.63M $- $-
Other Liabilities $- $- $- $- $- $- $- $- $- $-
Total Liabilities $656.51M $594.21M $590.35M $683.10M $756.01M $355.02M $42.56M $33.19M $3.64M $3.20M
Preferred Stock $- $- $- $- $- $- $- $- $92.05M $77.19M
Common Stock $12.00K $12.00K $11.00K $10.00K $8.00K $6.39K $5.63K $5.03K $843 $843
Retained Earnings $-3.04B $-2.84B $-2.31B $-1.66B $-926.35M $-581.47M $-276.77M $-149.26M $-98.26M $-71.13M
Accumulated Other Comprehensive Income Loss $-3.31M $-3.54M $-875.00K $-2.09M $-117.00K $-153.78K $-122.81K $- $- $-0
Other Total Stockholders Equity $3.27B $3.04B $2.48B $1.86B $1.13B $615.85M $437.86M $298.20M $30.00M $28.92M
Total Stockholders Equity $228.54M $194.52M $169.87M $198.66M $204.56M $34.23M $160.97M $148.94M $23.79M $34.98M
Total Equity $228.54M $194.52M $169.87M $198.66M $204.56M $34.23M $160.97M $148.94M $23.79M $34.98M
Total Liabilities and Stockholders Equity $885.05M $788.73M $760.22M $881.76M $960.57M $389.24M $203.53M $182.13M $27.43M $38.18M
Minority Interest $- $- $- $- $- $- $- $- $- $-
Total Liabilities and Total Equity $885.05M $788.73M $760.22M $881.76M $960.57M $389.24M $203.53M $182.13M $27.43M $38.18M
Total Investments $- $4.35M $6.50M $60.36M $311.87M $- $- $- $- $-
Total Debt $469.78M $110.93M $112.71M $210.22M $377.73M $157.03M $27.04M $26.39M $- $-
Net Debt $58.49M $-240.26M $-439.09M $-429.97M $-188.05M $-194.95M $-149.22M $-149.25M $-24.86M $-36.00M

Cash Flow Statement

Operating Cash Flow
Investing Cash Flow
Operating and Investing Cash Flow$400.00M$400.00M$200.00M$200.00M$0.00$0.00-$200.00M-$200.00M-$400.00M-$400.00M-$600.00M-$600.00M20162016201720172018201820192019202020202021202120222022202320232024202420252025
Financing Cash Flow$800.00M$800.00M$600.00M$600.00M$400.00M$400.00M$200.00M$200.00M$0.00$0.0020162016201720172018201820192019202020202021202120222022202320232024202420252025
Breakdown December 31, 2024 December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020 December 31, 2019 December 31, 2018 December 31, 2017 December 31, 2016 December 31, 2015
Net Income $-197.88M $-528.63M $-652.17M $-746.35M $-344.87M $-304.71M $-127.50M $-51.01M $-27.12M $-46.52M
Depreciation and Amortization $1.80M $1.70M $1.49M $1.49M $637.00K $239.68K $- $11.94K $- $-
Deferred Income Tax $- $- $- $198.26M $103.03M $16.34M $- $153.69K $- $-
Stock Based Compensation $114.13M $105.94M $91.08M $70.67M $45.38M $21.14M $7.73M $5.42M $1.08M $545.70K
Change in Working Capital $- $-200.17M $-15.70M $-93.52M $19.59M $53.15M $-12.04M $-1.19M $42.57K $628.31K
Accounts Receivables $-58.48M $- $2.38M $-10.10M $- $- $- $- $- $-
Inventory $-10.76M $- $-69.40M $-16.32M $- $- $- $- $- $-
Accounts Payables $1.09M $170.00K $18.69M $10.49M $-54.00K $-1.64M $6.59M $932.30K $69.78K $1.73M
Other Working Capital $- $-200.34M $32.63M $-77.59M $19.64M $54.79M $-18.63M $-2.12M $-27.21K $-1.10M
Other Non Cash Items $-5.91M $26.41M $61.55M $6.33M $15.76M $2.70M $568.33K $13.56K $1.01M $26.49M
Net Cash Provided by Operating Activities $-87.87M $-594.74M $-513.75M $-563.13M $-160.49M $-211.14M $-131.24M $-46.60M $-26.00M $-18.86M
Investments in Property Plant and Equipment $-403.00K $-773.00K $-1.52M $-1.10M $-5.42M $-1.69M $- $- $- $-
Acquisitions Net $- $- $-61.42M $-248.72M $311.57M $- $- $- $- $-
Purchases of Investments $- $- $-331.86M $-171.28M $-879.07M $- $- $- $- $-
Sales Maturities of Investments $- $- $393.28M $420.00M $567.50M $- $- $- $- $-
Other Investing Activities $- $99.00K $61.42M $248.72M $-311.57M $- $- $- $- $-
Net Cash Used for Investing Activities $-403.00K $-674.00K $59.89M $247.62M $-316.99M $-1.69M $- $- $- $-
Debt Repayment $365.45M $- $- $- $322.87M $184.21M $- $26.36M $- $-
Common Stock Issued $- $384.39M $380.12M $380.36M $381.42M $109.58M $131.19M $150.06M $14.86M $1.72K
Common Stock Repurchased $4.51M $- $- $- $- $- $- $- $- $-
Dividends Paid $- $- $- $- $- $- $- $- $- $-
Other Financing Activities $-216.21M $10.11M $-14.46M $11.87M $369.30M $204.33M $709.36K $20.95M $14.86M $41.23M
Net Cash Used Provided by Financing Activities $149.24M $394.50M $365.66M $392.24M $692.18M $388.54M $131.90M $197.38M $14.86M $41.24M
Effect of Forex Changes on Cash $-659.00K $135.00K $-488.00K $-2.02M $359.00K $4.70K $-38.43K $- $- $-
Net Change in Cash $60.31M $-200.78M $-88.68M $74.71M $215.06M $175.72M $624.14K $150.78M $-11.14M $22.38M
Cash at End of Period $412.61M $352.30M $553.07M $641.75M $567.04M $351.99M $176.27M $175.64M $24.86M $36.00M
Cash at Beginning of Period $352.30M $553.07M $641.75M $567.04M $351.99M $176.27M $175.64M $24.86M $36.00M $13.62M
Operating Cash Flow $-87.87M $-594.74M $-513.75M $-563.13M $-160.49M $-211.14M $-131.24M $-46.60M $-26.00M $-18.86M
Capital Expenditure $-403.00K $-773.00K $-1.52M $-1.10M $-5.42M $-1.69M $- $- $- $-
Free Cash Flow $-88.27M $-595.51M $-515.27M $-564.23M $-165.91M $-212.83M $-131.24M $-46.60M $-26.00M $-18.86M